The Magnitude of Decrease in Hepatic Very Low Density Lipoprotein Apolipoprotein B Secretion Is Determined by the Extent of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibition in Miniature Pigs1

Brown, 1986, A receptor-mediated pathway for cholesterol homeostasis., Science, 232, 34, 10.1126/science.3513311

Hampton, 1996, The biology of HMG-CoA reductase: the pros of contra-regulation., Trends Biochem Sci, 21, 140, 10.1016/S0968-0004(96)80168-X

Davignon, 1992, HMG-CoA reductase inhibitors: a look back and a look ahead., Can J Cardiol, 8, 843

Henwood, 1988, Lovastatin. A preliminary review of its pharmacodynamic properties and therapeutic use in hyperlipidaemia., Drugs, 36, 429, 10.2165/00003495-198836040-00003

Plosker, 1995, Simvastatin. A reappraisal of its pharmacology and therapeutic efficacy in hypercholesterolaemia., Drugs, 50, 334, 10.2165/00003495-199550020-00009

Haria, 1997, Pravastatin. A reappraisal of its pharmacological properties and clinical effectiveness in the management of coronary heart disease., Drugs, 53, 299, 10.2165/00003495-199753020-00008

Plosker, 1996, Fluvastatin. A review of its pharmacology and use in the management of hypercholesterolaemia., Drugs, 51, 433, 10.2165/00003495-199651030-00011

Lea, 1997, Atorvastatin. A review of its pharmacology and therapeutic potential in the management of hyperlipidaemias., Drugs, 53, 828, 10.2165/00003495-199753050-00011

McClellan, 1998, Cerivastatin., Drugs, 55, 415, 10.2165/00003495-199855030-00009

Thompson, 1996, Role of cholesterol in regulating apolipoprotein B secretion by the liver., J Lipid Res, 37, 439, 10.1016/S0022-2275(20)37589-1

Huff, 1997, 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors and hepatic apolipoprotein B secretion., Curr Opin Lipidol, 8, 138, 10.1097/00041433-199706000-00003

Aguilar-Salinas, 1998, Metabolic modes of action of the statins in the hyperlipoproteinemias., Atherosclerosis, 141, 203, 10.1016/S0021-9150(98)00198-1

Roth, 1991, Relationship between tissue selectivity and lipophilicity for inhibitors of HMG-CoA reductase., J Med Chem, 34, 463, 10.1021/jm00105a071

Bocan, 1992, Hepatic and nonhepatic sterol synthesis and tissue distribution following administration of a liver selective HMG-CoA reductase inhibitor, CI-981: comparison with selected HMG-CoA reductase inhibitors., Biochim Biophys Acta, 1123, 133, 10.1016/0005-2760(92)90103-3

Dart, 1997, A multicenter, double-blind, one-year study comparing safety and efficacy of atorvastatin versus simvastatin in patients with hypercholesterolemia., Am J Cardiol, 80, 39, 10.1016/S0002-9149(97)00280-4

Jones, 1998, Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin with hypercholesterolemia (the CURVES study)., Am J Cardiol, 81, 582, 10.1016/S0002-9149(97)00965-X

Watts, 1995, Direct correlation between cholesterol synthesis and hepatic secretion of apolipoprotein B-100 in normolipidemic subjects., Metabolism, 44, 1052, 10.1016/0026-0495(95)90104-3

Naoumova, 1996, Plasma mevalonic acid, an index of cholesterol synthesis in vivo, and responsiveness to HMG-CoA reductase inhibitors in familial hypercholesterolaemia., Atherosclerosis, 119, 203, 10.1016/0021-9150(95)05649-1

Naoumova, 1997, Prolonged inhibition of cholesterol synthesis explains the efficacy of atorvastatin., J Lipid Res, 38, 1496, 10.1016/S0022-2275(20)37432-0

Mahley, 1975, Swine lipoproteins and atherosclerosis. Changes in the plasma lipoproteins and apoproteins induced by cholesterol feeding., Biochemistry, 14, 2817, 10.1021/bi00684a005

Marcel, 1978, Low density lipoprotein turnover in swine., Can J Biochem, 56, 963, 10.1139/o78-150

Huff, 1985, Direct synthesis of low-density lipoprotein apoprotein B in the miniature pig., Metabolism, 34, 36, 10.1016/0026-0495(85)90057-5

Arad, 1990, Lovastatin therapy reduces low density lipoprotein apoB levels in subjects with combined hyperlipidemia by reducing the production of apoB-containing lipoproteins: implications for the pathophysiology of apoB production., J Lipid Res, 31, 567, 10.1016/S0022-2275(20)42825-1

Huff, 1985, Mevinolin and cholestyramine inhibit the direct synthesis of low density lipoprotein apolipoprotein B in miniature pigs., J Lipid Res, 26, 1175, 10.1016/S0022-2275(20)34265-6

Huff, 1989, Regulation of low density lipoprotein apoprotein B metabolism by lovastatin and cholestyramine in miniature pigs: effects on LDL composition and synthesis of LDL subfractions., Metabolism, 38, 256, 10.1016/0026-0495(89)90084-X

Burnett, 1997, Inhibition of HMG-CoA reductase by atorvastatin decreases both VLDL and LDL apoB production in miniature pigs., Arterioscler Thromb Vasc Biol, 17, 2589, 10.1161/01.ATV.17.11.2589

Sniderman, 1993, Substrate delivery as a determinant of hepatic apoB secretion., Arterioscler Thromb, 13, 629, 10.1161/01.ATV.13.5.629

Sparks, 1994, Insulin regulation of triacylglycerol-rich lipoprotein synthesis and secretion., Biochim Biophys Acta, 1215, 9, 10.1016/0005-2760(94)90088-4

Yao, 1994, Synthesis and secretion of hepatic apolipoprotein B-containing lipoproteins., Biochim Biophys Acta, 1212, 152, 10.1016/0005-2760(94)90249-6

Ginsberg, 1995, Synthesis and secretion of apolipoprotein B from cultured liver cells., Curr Opin Lipidol, 6, 275, 10.1097/00041433-199510000-00006

Huff, 1994, Inhibition of hepatic ACAT decreases apoB secretion in miniature pigs fed a cholesterol-free diet., Arterioscler Thromb, 14, 1498, 10.1161/01.ATV.14.9.1498

Folch, 1957, A simple method for the isolation and purification of total lipides from animal tissues., J Biol Chem, 226, 497, 10.1016/S0021-9258(18)64849-5

Shapiro, 1969, Thin-layer chromatographic assay for HMG-CoA reductase and mevalonic acid., Anal Biochem, 31, 383, 10.1016/0003-2697(69)90279-6

Gallo, 1987, Normal cholesterol absorption in rats deficient in intestinal acyl coenzyme A:cholesterol acyltransferase activity., J Lipid Res, 28, 381, 10.1016/S0022-2275(20)38691-0

Kieft, 1991, Rapid on-line determination of cholesterol distribution among plasma lipoproteins after high-performance gel filtration chromatography., J Lipid Res, 32, 859, 10.1016/S0022-2275(20)42037-1

Snedecor, 1967, 94

Ness, 1998, Atorvastatin action involves diminished recovery of hepatic HMG-CoA reductase activity., J Lipid Res, 39, 75, 10.1016/S0022-2275(20)34205-X

Liscum, 1995, Intracellular cholesterol transport and compartmentation., J Biol Chem, 270, 15443, 10.1074/jbc.270.26.15443

Conde, 1996, Hypocholesterolemic actions of atorvastatin are associated with alterations on hepatic cholesterol metabolism and lipoprotein composition in the guinea pig., J Lipid Res, 37, 2372, 10.1016/S0022-2275(20)37486-1

Synouri-Vrettakou, 1983, Acyl-coenzyme A: cholesterol acyltransferase. Transfer of cholesterol to its substrate pool and modulation of activity., Eur J Biochem, 133, 299, 10.1111/j.1432-1033.1983.tb07462.x

Billheimer, 1990, 7

Havekes, 1987, Cellular free cholesterol in HepG2 cells is only partially available for downregulation of low density lipoprotein receptor activity., Biochem J, 247, 739, 10.1042/bj2470739

Mohammadi, 1998, Effect of atorvastatin on intracellular stability and secretion of apolipoprotein B in HepG2 cells., Arterioscler Thromb Vasc Biol, 18, 783, 10.1161/01.ATV.18.5.783

Bergstrom, 1998, Hepatic responses to inhibition of 3-hydroxy-3-methylglutaryl-CoA reductase: a comparison of atorvastatin and simvastatin., Biochim Biophys Acta, 1389, 213, 10.1016/S0005-2760(97)00182-3

Wilcox, 1999, Differential regulation of apolipoprotein B secretion from HepG2 cells by two HMG-CoA reductase inhibitors, atorvastatin and simvastatin., J Lipid Res, 40, 1078, 10.1016/S0022-2275(20)33512-4

Wu, 1994, Exogenous VLDL stimulates apolipoprotein B secretion from HepG2 cells by both pre- and post-translational mechanisms., J Lipid Res, 35, 1200, 10.1016/S0022-2275(20)39963-6

Fast, 1995, Nascent VLDL phospholipid composition is altered when phosphatidylcholine biosynthesis is inhibited: evidence for a novel mechanism that regulates VLDL secretion., Biochim Biophys Acta, 1258, 159, 10.1016/0005-2760(95)00116-T

Burnett, 1998, Inhibition of cholesterol esterification by DuP 128 decreases hepatic apolipoprotein B secretion in vivo: effect of dietary fat and cholesterol., Biochim Biophys Acta, 1393, 63, 10.1016/S0005-2760(98)00059-9

Burnett, 1999, Inhibition of ACAT by avasimibe decreases both VLDL and LDL apolipoprotein B production in miniature pigs., J Lipid Res, 40, 1317, 10.1016/S0022-2275(20)33494-5

Wang, 1996, The microsomal triglyceride transfer protein facilitates assembly and secretion of apolipoprotein B-containing lipoproteins and decreases cotranslational degradation of apolipoprotein B in transfected COS-7 cells., J Biol Chem, 271, 14124, 10.1074/jbc.271.24.14124

Du, 1996, Translocation of apolipoprotein B across the endoplasmic reticulum is blocked in abetalipoproteinemia., J Lipid Res, 37, 1309, 10.1016/S0022-2275(20)39160-4

Jamil, 1995, Microsomal triglyceride transfer protein. Specificity of lipid binding and transport., J Biol Chem, 270, 6549, 10.1074/jbc.270.12.6549